This research report titled “Primary Sclerosing Cholangitis-Pipeline Review, H2 2019” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Primary Sclerosing Cholangitis during the period 2019. The concerned sector is ... Read more
Primary Sclerosing Cholangitis (PSC) is a rare, progressive liver disease characterized by inflammation and scarring of the bile ducts that causes them to narrow. Over time, the bile duct damage caused by PSC prevents the liver from functioning properly. The current treatment landscape focuses on reducing symptoms and managing them effectively. However, there is a pressing need for developing curative treatment options to address its rising prevalence.
Primary Sclerosing Cholangitis (PSC) is a rare, progressive disease that attacks and damages the bile ducts of the liver, leading to fibrosis and scarring of the ducts over time. This can cause several complications and eventually lead to liver failure if left untreated. In this article, we will discuss in detail about this serious liver condition.
What is Primary Sclerosing Cholangitis?
Primary Sclerosing Cholangitis (PSC) is a chronic progressive liver disease ... Read more
